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1023-101 Pred ic t ive  Ab i l i ty  o f  Co lo r  M-Mode and Doppler Tissue 
Imaging Compared  to Trad i t iona l  Measures  o f  D iasto l ic  
Dysfunction in Ch i ld ren  
Adel K. Younoszai. Mario Garcia, Daniel Murphy, The Cleveland Clinic Foundation, 
Cleveland, Ohio. 
Backaround: There is no reliable echocardiographic method of evaluating diastolic func- 
tion in children. Two new modalities, Color M-mode (CMM) and Doppler tissue imaging 
(DTI), are used in adults. We evaluated their ability to identify patients with abnormal car- 
diac function and compared them to traditional methods. 
Methods: Measurements were made in two groups: 1) Normal - referred to rule out dis- 
ease with a normal echocardiogram [ n = 27 (14 male), mean age = 8.1yr (range: 0.05 - 
17)], and 2) Cardiomyopathy - diagnosis of dilated, hypertrophic or restrictive cardiomy- 
opathy In = 22 (14 male), mean age = 13.9 yr (range: 1.6 - 19.6)]. Echocardiogrephic 
measurements included: mitral E and A waves, deceleration time, pulmonary vein S, D, 
and A reversal waves, isovolumic relaxation time, CMM derived propagation velocity (Vp) 
of the mitral inflow, and DTI derived early diastolic velocity (Era) of the four margins of the 
mitral annulus. Receiver operating characteristic analysis was performed on all measure- 
ments. 
Results: 
Measure Area under curve Standard error 
E wave 0.685 0,076 
A wave 0.591 0.082 
Deceleration time 0.328 0.079 
S wave 0.476 0,084 
D wave 0.658 0.079 
A reversal wave 0.307 0.079 
IVRT 0.507 0.090 
Vp 0.826 0.061 
Em septal 0.924 0.039 
Em anterior 0.895 0,046 
Em lateral 0.891 0.047 
Em posterior 0.878 0.050 
Conclusions: All Em measurements and Vp have very strong predictive abilities, Other 
measures have mild-to-no predictive ability to separate healthy from abnormal patients. 
Both CMM and DTI are promising adjuncts to traditional echocardiogrephic methods of 
evaluating diastolic function. Future studies should include establishment of age- 
adjusted normal data and correlation with clinical and hemodynamic measure of cardiac 
dysfunction. 
1023-102 Digital  3-D Ve loc i ty  Reconstructions Allow Ext rac t ion  o f  
the Vena Cont rac ts  (VC) Area fo r  F low Rate 
Computation: An In V i t ro  S tudy  Using Raw Scan l ine  
T rans fer  and Reconstruction of 3-D Data 
Yoshiki Mort, Paul R. Detmer, Xiang-Ning Li, Roy W. Martin, Antoinette Kenny, Susan L. 
Martin, David J. Sahn, Oregon Health & Science Universi~ Portland, Oregon, ATL 
Ultrasound, Bothell, Washington. 
Methods: Our study imaged proximal jet flows from 3 orifices (rectangular, circular and 
triangular, each 0.24 cm =) with an ATL 3000 using a 5MHz multiplane probe with stepper 
function controlled by the scanner and a connection allowing transfer of raw scanUne dig- 
ital velocity data to an SGI workstation. By interrogating jet flow in the in vitro model 
(stroke volumes 10-60 cc/beat measured by an ultrasonic flowmeter) parallel to the direc- 
tion of propagation and analyzing it in a cross-section selected for smallest diameter and 
flattest velocity profile, a high velocity core in the VC region could be identified. Results: 
After rotational acquisition at 5 ° spacing, 3D digital color VC regions extracted and mea- 
sured as cress-sectional areas matched the fluid dynamically determined effective orifice 
area (EOA) for the modeled valve defects (p = NS, mean difference + 0.06 crn~). Also, 
when VC area was integrated with the CW Doppler velocity time integral, a high correla- 
tion with beth actual peak instantaneous flow rate 3.7-11.4 L/rain (r = 0.98)(slight overes- 
timation) and stroke volume/beet (r = 0.98) was obtained. VC areas had extreme 
similarity to the orifices' shapes. Conclusions: The ability to analyze cross-sectional dig- 
ital velocity data from proximal jet flow fields from 3D datasets obtained parallel to flow 
enhances measurement of VC as a reflection of EOA. 
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1047-97 Ef fect  of Vssodilator Therapy on Left  A t r lovent r l cu la r  
Va lve Regurg i ta t ion  Af ter  A t r iovent r i cu la r  Septa l  Defect  
Repai r  
Reenu S. Eacen, Claudio Ramaciotti, Matthew S. Lemler, Daniel Stromberg, University 
of Texas, Southwestern Medical Center, Dallas, Texas. 
Background: Postoperative left atrioventricular valve (LAVV) regurgitation after atrioven- 
tricular septal defect (AVSD) repair is a significant risk factor for morbidity and mortality, 
We performed a prospective study to determine whether vasodilator therapy with Nitro- 
prusslde changes the severity of LAVV regurgitation after AVSD repair. 
Methods: Postoperative patients received a Nitroprusslde infusion at 0.5mcg/kg/min, 
fitreted to a maximum dose of 2mcg/kg/min in an attempt to decrease systolic blood 
pressure by 15%. The vena contracta of the LAVV regurgitant jet, and regurgitant fraction 
across the LAW were measured before and during Nitroprusside administration by tran- 
sthoracic echocardiogrephy. All measurements were made off line in blinded fashion. 
Cardiac output and systemic vascular resistance (SVR) were evaluated during the study 
periods using arterial and venous blood gases. 
Results: Of the 17 patients studied, 6 patients achieved both a decrease in systolic blood 
pressure and a significant reduction of SVR (> 10%) during Nitroprusside infusion. These 
patients had a significant increase in their cardiac output (15.6%, p=0.002), decrease in 
the vena contracta of the regurgitant jet in the apical four chamber view (29.5%, p=0.03) 
and a decrease in the LAVV regurgitant fraction (35,9%, p=0.025). Those patients who 
did not demonstrate a decrease in SVR, whether or not accompanied by a decrease in 
blood pressure (via decreased stroke volume, n=5), did not experience a reduction in 
LAVV regurgitation. 
Conclusions: 1, Vasodilator administration which diminishes SVR augments cardiac out- 
put and decreases LAVV regurgitation after AVSD repair. 2. Vasodilation that solely 
achieves a reduction in blood pressure without an accompanying decrease in SVR does 
not reduce LAVV regurgitation in postoperative AVSD patients. 
1047-98 Carved i lo l  fo r  the  Treatment  o f  Congest ive  Heart  Fa i lure 
in Ch i ld ren  With Csrdlomyopathy 
Paolo Rusconi. Esmail Redha, Jennifer R. Marin, Maria Rossique-Gonzalez, Ming-Lon 
Young, Grace S. Wolff, University of Miami School of Medicine, Miami, Florida, Jackson 
Memorial Hospital, Miami, Florida. 
Background: Carvedilol (CAR) has proven to be effective in the treatment of congestive 
heart failure (CHF) in adults. However there is paucity of data on the use of beta-block- 
ers, their safety and efficacy in the treatment of CHF in children. Our goal is to assess 
safety and efficacy of CAR in the treatment of CHF in children. 
Methods: Retrospective analysis of clinical data of 22 children with cardiomyopathy 
(CMP) and CHF who received CAR after conventional treatment with Digoxin, Angio- 
tensin Converting Enzyme Inhibitor and diuretics. Change in clinical status before and 
after CAR treatment was assessed using New York Heart Association (NYHA) class. 
Echocerdiogrem was performed before starting CAR and at 3-6 months interval to moni- 
tor ejection fraction (EF) and spbencity index (ratio between left ventricle transverse 
diameter and left ventricle longitudinal diameter in diastole and multiplied by 100). CAR 
was started (mean initial dose=0.1 mg/Kg/day in two divided doses), at a median of 10.6 
months after the diagnosis of CMP was made. CAR was increased weekly to an average 
maximum dose of 0.8 mg/Kg/day (0.25-1.2). 
Results: There were 13 males, median age: 8.9 years (0.5-18). CMP etiology: idiopathic 
11, myocardifis 5, muscular dystrophy 3, others 3. NYHA classification was >~2 in all 
patients; 8 children ware in class 4. All patients had EF .~=40%. In 2 patients CAR was 
stopped after 1 week because of worsening CHF in one and asthma in the other. Mean 
follow up was 19.5 months (2.7-37). Four patients died 1 awaiting transplant and 3 with 
muscular dystrophy. Three patients underwent heart transplant. One child developed first 
and Mobitz I second degree atrioventricular block, EF improved from 27+7% before CAR 
was started to 39~12% (mean improvement 12.5%, p< 0.001), The average sphericity 
index decreased from 85t-9% to 79:t:11% (mean change 9.4%, p<0,005). NYHA class 
improved from 3.15 to 1,95 (p<0.001). 
Conclusion: When used in combination with standard therapy CAR is well tolerated and 
seems to improve clinical status and cardiac function of children with CHF. Control stud- 
ies with a larger number of patients are required to determine if CAR improves mortality 
and reduce hospitalization in this age group. 
1047-99 A Medical  S t rategy to Address  Pers i s tent  Chest  Tube 
Dra inage Af ter  the Fontan  Operat ion  
Joseah R. Cava. Raymond T. Fedderly, Sarah M. Bevandic, Michelle Steitzer, Patrick J. 
Phelan, Kan N. Hor, James S. Tweddell, S. Bert Litwin, Medical College of Wisconsin, 
Milwaukee, Wisconsin, Children's Hospital of Wisconsin, Milwaukee, Wisconsin. 
Background: Surgical modifications have dramatically improved survival following the 
Fontan operation; however, morbidity related to persistent pleural effusion continues to 
be a significant problem. Total parenteral nutrition (TPN) along with eliminating feedings 
(NPO) and pleurel sclerosis have been used to treat persistent drainage. Risk factors for 
persistent pleural drainage have been previously reported, although medical manage- 
ment in this population of patients varies widely, A standardized medical management 
